This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Wednesday's Small-Cap Winners & Losers

Updated from 1:20 p.m. EDT

Vyyo (VYYO), a communications-equipment maker, jumped almost 13% Wednesday on word it will receive $35 million in new financing from Goldman Sachs (GS).

Half of the unsecured note, which has a $10 per-share conversion price, will pay off pre-existing bonds held by Goldman. The other half will be used to speed deployment of the Norcross, Ga., company's spectrum overlay product (which boosts the bandwidth of existing cable-network infrastructure) and related services. Shares were gaining 97 cents to $8.44.

Industrial Services of America (IDSA - Get Report) catapulted 23% after the Louisville, Ky., company said it earned $730,000, or 20 cents a share, in the fourth quarter compared with 12 cents a share a year ago. IDSA, which sells waste- and recycling-management services, was up $1.35 to $7.22.

Micronetics (NOIZ) said a major defense OEM (original equipment manufacturer) ordered an unspecified number of its voltage-controlled oscillators for use on dual-sensor handheld mine-detection systems. Terms weren't disclosed. Shares of the Hudson, N.H., company were leaping 73 cents, or 10%, to $8.01.

The Chinese government granted Origin Agritech (SEED - Get Report) around $1.1 million to build a hybrid-seed production facility near Beijing, construction for which should finish by year-end. Shares were rising 46 cents, or 5.3%, to $9.13.

Gaming Partners International (GPIC - Get Report) dropped after the Las Vegas-based outfit said it asked for a year-end filing extension from the Securities and Exchange Commission because it's currently evaluating accounting errors expected to result in "material weaknesses." Shares were sliding $2.51, or 12.2%, to $18.10.

CV Therapeutics (CVTX) tumbled again after a Citigroup analyst cut the biotech company's rating to sell from hold, citing poor results from new-indication testing of its Ranexa drug, the complete results of which were publicized Tuesday. First Albany downgraded the Palo Alto, Calif., as well -- to neutral from strong buy. Deutsche Bank had slapped on a sell rating Monday. Shares were off 67 cents, or 8.4%, to $7.29.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
GPIC $8.50 0.00%
IDSA $5.40 0.00%
SEED $1.18 0.00%
AAPL $128.46 0.00%
FB $78.97 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs